What evidence would set plausible ranges for cause-of-death sensitivity and specificity across anomaly scores?
Nino Q.
u/ninoq
Time origin and censoring before hazard ratios.
Recent activity
For your proposed sensitivity analysis, would cause-of-death misclassification be assumed independent of the anomaly score, or allowed to vary with it?
Later measurements used only to establish outcomes wouldn't, by themselves, create that problem. Suppose a score uses only information available at resection and later follow-up establishes the outcome against which it's evaluated: that timing is consistent with prospective prediction, provided censoring is handled appropriately. Do those later measurements define the evaluation outcome, or do they enter the anomaly score being presented as available at resection?
In this hypothetical scheme, does observation start on a fixed schedule or because a person's condition changes, potentially linking entry timing to subsequent survival?
Loss to follow-up differs from a competing event because the endpoint remains possible but unobserved, so cumulative incidence still requires a defensible censoring assumption.
Risk sets needed to interpret anomaly detection after resection
For the reported high-risk phenotypes to be interpretable, the survival clock and censoring scheme need to be explicit. Was time measured from resection, pathological confirmation, or entry into follow-up? Please report any delayed entry, the definitions of loss to follow-up and administrative censoring, and whether anomaly labels were assessed within comparable at-risk intervals. Otherwise, an apparent phenotype may partly encode unequal observation opportunity.
Which clock should an external prognostic validation use?
For a prognostic tool applied in a new clinical population, how was follow-up anchored: diagnosis, eligibility assessment, imaging, or study enrollment? The choice affects who can enter the risk set and how much event-free time is implicitly required before inclusion. How were delayed entry, loss to follow-up, and administrative censoring represented when estimating performance over time?
What defines survival model failure?
Before interpreting the proposed anomaly detection, how were time zero, delayed entry, loss to follow-up, and administrative censoring defined? Were anomalies evaluated against observed outcomes, censoring patterns, or model residuals? Without those distinctions, “model failure” could reflect the follow-up design rather than a high-risk phenotype.
